1. Home
  2. HGLB vs BNR Comparison

HGLB vs BNR Comparison

Compare HGLB & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Highland Global Allocation Fund

HGLB

Highland Global Allocation Fund

HOLD

Current Price

$9.52

Market Cap

207.7M

Sector

Finance

ML Signal

HOLD

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

HOLD

Current Price

$19.76

Market Cap

233.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HGLB
BNR
Founded
1998
2014
Country
United States
China
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
207.7M
233.7M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
HGLB
BNR
Price
$9.52
$19.76
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
91.8K
59.8K
Earning Date
01-01-0001
11-20-2025
Dividend Yield
13.16%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$75,749,382.00
Revenue This Year
N/A
$136.32
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
5.56
52 Week Low
$6.42
$2.18
52 Week High
$9.45
$23.59

Technical Indicators

Market Signals
Indicator
HGLB
BNR
Relative Strength Index (RSI) 46.36 61.34
Support Level $9.46 $17.66
Resistance Level $10.11 $23.59
Average True Range (ATR) 0.31 2.75
MACD 0.01 0.33
Stochastic Oscillator 55.19 68.06

Price Performance

Historical Comparison
HGLB
BNR

About HGLB Highland Global Allocation Fund

Highland Global Allocation Fund is a diversified, closed-end management investment company. The investment objective of the Fund is to seek long-term growth of capital and future income. The Fund seeks to achieve its investment objectives by investing in a portfolio of U.S. and foreign equity, debt, and money market securities. It may also invest in senior loans to domestic or foreign corporations, partnerships, and other entities that operate in a variety of industries and geographic regions.

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

Share on Social Networks: